amgen’s prolia gets fda boxed warning for risk of severe hypocalcemia
Published 7 months ago • 170 plays • Length 0:37Download video MP4
Download video MP3
Similar videos
-
4:01
fda adds boxed warning for increased risk of severe hypocalcemia in patients with advanced chroni...
-
0:37
sandoz’s jubbonti & wyost approved as interchangeable biosimilars to amgen’s prolia & xgeva
-
4:01
fda investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medi...
-
3:36
alert! fda drops bombshell on prolia for osteoporosis
-
4:33
why fda added boxed warning to denosumab for ckd?#osteoporosis #denosumabinjection #news #ckd
-
4:17
dr. avital harari on osteoporosis and your parathyroid glands
-
2:17
denosumab - xgeva - prolia in a nutshell.
-
2:05
osteoporosis 101: what is osteoporosis and what you need to know
-
3:22
james foran: does decitabine maintenance improve survival in older patients with aml?
-
1:31
calcium disorders
-
10:06
osteoporosis
-
3:55
calcium
-
2:57
osteoporosis
-
2:34
new salvage treatment for aml/mds after allogeneic transplant: the viola trial
-
1:51
dr manolagas osteoporosis
-
5:48
criteria used in the diagnosis of osteoporosis
-
7:57
quick hits in lab medicine: ca mg po4 and bone mineral balance
-
3:40
how is hypoparathyroidism managed?
-
0:58
know your lp(a) & ldl (“bad”) cholesterol levels to understand your heart health.